Skip to content

In the BioHarmony Drug Report Database

Sulindac

Clinoril (sulindac) is a small molecule pharmaceutical. Sulindac was first approved as Clinoril on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, gouty arthritis, inflammation, and osteoarthritis amongst others in the USA. It is known to target prostaglandin G/H synthase 2, retinoic acid receptor RXR-alpha, and prostaglandin G/H synthase 1.
Trade Name Clinoril
Common Name Sulindac
Indication ankylosing spondylitis, bursitis, gouty arthritis, inflammation, osteoarthritis, rheumatoid arthritis, shoulder pain, tendinopathy
Drug Class Anti-inflammatory agents (acetic acid derivatives)
Sulindac
Get full access now